A33T (p.Ala33Thr) variant of KRT3 (Keratin, type II cytoskeletal 3)

A33T (p.Ala33Thr) in KRT3 (Keratin, type II cytoskeletal 3) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The available variant effect predictions contribute to a CATVariant prioritization score of 0.28 / 1. The record also includes population frequency data and structural context.

A33T (p.Ala33Thr) variant details